Biomaterials Market by Type of Materials (Metallic, Ceramic, Polymers, Natural) & Application (Cardiovascular, Orthopedic, Dental, Plastic Surgery, Wound Healing, Neurology, Tissue Engineering, Ophthalmology) - Global Forecast to 2021

 Published On: Jan, 2017 |    No of Pages: 264 |  Published By: MarketsandMarkets | Format: PDF
Request Free Sample
The biomaterials market is projected to reach 149.17 billion by 2021 million from 70.90 billion in 2016, at a CAGR of 16.0%.

Factors such as increasing funds and grants by governments worldwide, rising incidence of cardiovascular diseases, technological advancements, the growing implantable devices market, globally rising cases of hip and knee replacement procedures, rising awareness of tissue engineering, and high growth in geriatric population are driving the growth of the market. On the other hand, stringent clinical and regulatory processes and unfavorable healthcare reforms in the U.S., is expected to restrain the growth of the market.

The demand for biodegradable polymers has increased, owing to its superior biocompatibility and ability to slowly degrade inside the body, thus eliminating the need for removal. Superior physicochemical & biocompatible properties and the increasing application areas of polymeric materials are likely to boost the growth of the market. However, polymers are costly, which can hinder the growth of this market. A biomaterial is a natural or synthetic material suited to replace or treat natural body tissues and organs on interaction with biological systems.

The plastic surgery segment is expected to grow at the highest CAGR during forecast period, due to growing number of elderly people, positive public perception towards cosmetic surgeries, and technological advances are factors increasing the demand for plastic surgeries. In 2016, the cardiovascular segment is expected to account for the largest share of the market, due to factors such as increasing prevalence of cardiovascular diseases, increasing angiography procedures, and growing usage of cardiac stents that are considered a safe option for coronary angioplasty treatment.

In 2016, North America is expected to account for the largest share of the global biomaterial market, followed by Europe, Asia-Pacific, and RoW. Rising biomaterial-based research, increasing demand for plastic surgeries, increasing conferences on biomaterials, growing cancer incidence, and the rising prevalence of cardiovascular diseases are expected to drive market growth in this region. In the coming years, the Asia-Pacific region is expected to grow at the highest CAGR during the forecast period. This growth can be attributed to factors such as increasing Japan’s growing healthcare industry, increasing aging population, and high incidence of cardiovascular diseases in India and China.

The market witnesses high competitive intensity, as there are several big and many small firms with similar product offerings. These companies adopt various strategies (agreements, partnerships, joint ventures, collaborations, expansions, new product launches, and acquisitions) to increase their market shares and establish a strong foothold in the global biomaterials market.

In-depth interviews were conducted with CEOs, sales and marketing directors, other innovation and technology directors, and executives from various key organizations operating in the biomaterials market.

- By Company Type: Tier 1: 34%, Tier 2: 38%, Tier 3: 28%
- By Designation: Director-level: 31%, C-level: 35%, Others: 34%
- By Region: North America: 28%, Europe: 31%, APAC: 24%, RoW: 17%

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn helps the firms to garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on the product portfolios of top players in the biomaterials market. The report analyzes the biomaterials market, by type of material and application
• Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the biomaterials market
• Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various biomaterials across regions
• Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the biomaterials market
• Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the biomaterials market
TABLE OF CONTENTS

1 INTRODUCTION 23
1.1 OBJECTIVES OF STUDY 23
1.2 MARKET DEFINITION 23
1.2.1 MARKETS COVERED 24
1.2.2 YEARS CONSIDERED FOR THE STUDY 24
1.3 CURRENCY 25
1.4 LIMITATIONS 25
1.5 STAKEHOLDERS 25

2 RESEARCH METHODOLOGY 26
2.1 RESEARCH METHODOLOGY STEPS 26
2.2 SECONDARY AND PRIMARY RESEARCH METHODOLOGY 27
2.2.1 SECONDARY RESEARCH 27
2.2.2 PRIMARY RESEARCH 28
2.2.2.1 Key data from primary sources 29
2.2.2.2 Key insights from primary sources 30
2.2.2.3 Key industry insights 31
2.3 MARKET SIZE ESTIMATION METHODOLOGY 31
2.4 RESEARCH DESIGN 33
2.5 MARKET DATA VALIDATION AND TRIANGULATION 34
2.6 ASSUMPTIONS FOR THE STUDY 35

3 EXECUTIVE SUMMARY 36
3.1 INTRODUCTION 36
3.2 CONCLUSION 43

4 PREMIUM INSIGHTS 44
4.1 GLOBAL BIOMATERIALS MARKET OVERVIEW 44
4.2 GLOBAL BIOMATERIALS MARKET, BY APPLICATION 45
4.3 GEOGRAPHIC ANALYSIS: BIOMATERIALS MARKET, BY TYPE 46
4.4 GEOGRAPHIC SNAPSHOT: BIOMATERIALS MARKET 47

5 MARKET OVERVIEW 48
5.1 INTRODUCTION 49
5.2 MARKET DYNAMICS 49
5.2.1 DRIVERS 50
5.2.1.1 Increased funds and grants by government bodies for the development of novel biomaterials 50
5.2.1.2 Increasing demand for implantable devices 51
5.2.1.3 Growing demand for biomaterials in plastic surgery and wound healing applications 51
5.2.1.4 Rising number of hip and knee replacement procedures 51
5.2.1.5 Rising geriatric population and the subsequent growth in incidence of cardiovascular diseases 52
5.2.1.6 Increasing awareness about regenerative medicine 52
5.2.2 RESTRAINTS 53
5.2.2.1 Stringent clinical & regulatory processes 53
5.2.2.2 Unfavorable healthcare reforms in the U.S. 53
5.2.3 OPPORTUNITIES 54
5.2.3.1 Growing healthcare market in emerging economies 54
5.2.3.2 Increasing number of free-trade agreements 54
5.2.4 CHALLENGES 55
5.2.4.1 Limitations of biomaterial-based products 55

6 REGULATORY ASSESSMENT 56
6.1 INTRODUCTION 56
6.2 U.S. 56
6.2.1 INTRODUCTION 56
6.2.2 FDA DEVICE CLASSIFICATION 57
6.2.3 U.S.: REGULATORY APPROVAL TIMELINE ASSESSMENT 59
6.2.4 STRINGENT FDA REGULATIONS GOVERNING PRODUCT APPROVALS 60
6.3 EUROPE 60
6.3.1 INTRODUCTION 60
6.3.2 EUROPEAN MEDICAL DEVICE CLASSIFICATION 61
6.3.3 EUROPE: REGULATORY APPROVAL TIMELINE ASSESSMENT 63
6.3.4 EUROPEAN REGULATORY PROCESS TO GET MORE STRINGENT IN FUTURE 63
6.4 JAPAN 64
6.4.1 INTRODUCTION 64
6.4.2 PMDA DEVICE CLASSIFICATION 64
6.4.3 JAPAN: REGULATORY APPROVAL TIMELINE ASSESSMENT 66
6.4.4 REVISION OF THE PHARMACEUTICAL AFFAIRS LAW (PAL) AND IMPLEMENTATION OF THE NEW PMD ACT IN JAPAN 66
6.5 CHINA 67
6.5.1 INTRODUCTION 67
6.5.2 CFDA DEVICE CLASSIFICATION 67
6.5.3 CHINA: REGULATORY APPROVAL TIMELINE ASSESSMENT 69
6.5.4 RISING HURDLES IN THE REGULATORY PROCESS IN CHINA 69
6.6 INDIA 70
6.6.1 INTRODUCTION 70
6.6.2 INDIA: REGULATORY APPROVAL TIMELINE ASSESSMENT 71
6.7 AUSTRALIA 72
6.7.1 INTRODUCTION 72
6.7.2 TGA DEVICE CLASSIFICATION 72
6.7.3 AUSTRALIA: REGULATORY APPROVAL TIMELINE ASSESSMENT 74

7 GLOBAL BIOMATERIALS MARKET, BY TYPE OF MATERIAL 75
7.1 INTRODUCTION 76
7.2 METALLIC BIOMATERIALS 77
7.2.1 STAINLESS STEEL 79
7.2.2 TITANIUM & TITANIUM ALLOYS 79
7.2.3 COBALT-CHROME ALLOYS 80
7.2.4 GOLD 81
7.2.5 SILVER 81
7.2.6 MAGNESIUM 82
7.3 CERAMICS 83
7.3.1 CALCIUM PHOSPHATE 84
7.3.2 ZIRCONIA 85
7.3.3 ALUMINUM OXIDE 85
7.3.4 CALCIUM SULFATE 86
7.3.5 CARBON 87
7.3.6 GLASS 87
7.4 POLYMERS 88
7.4.1 POLYMETHYLMETHACRYLATE (PMMA) 90
7.4.2 POLYETHYLENE 90
7.4.3 POLYESTER 91
7.4.4 POLYVINYLCHLORIDE (PVC) 92
7.4.5 SILICONE RUBBER 92
7.4.6 NYLON 93
7.4.7 POLYETHERETHERKETONE (PEEK) 94
7.4.8 POLYLACTIC ACID, POLY GLYCOLIC ACID, AND POLY(LACTIDE-CO-GLYCOLIDE) 94
7.4.9 OTHER POLYMERS 95
7.5 NATURAL BIOMATERIALS 96
7.5.1 HYALURONIC ACID 99
7.5.2 COLLAGEN 99
7.5.3 GELATIN 100
7.5.4 FIBRIN 100
7.5.5 CELLULOSE 101
7.5.6 CHITIN 101
7.5.7 ALGINATES 102
7.5.8 SILK 102

8 BIOMATERIALS MARKET, BY APPLICATION 104
8.1 INTRODUCTION 105
8.2 CARDIOVASCULAR 107
8.2.1 CATHETERS 109
8.2.2 STENTS 109
8.2.3 IMPLANTABLE CARDIAC DEFIBRILLATORS 110
8.2.4 PACEMAKERS 111
8.2.5 SENSORS 112
8.2.6 HEART VALVES 112
8.2.7 VASCULAR GRAFTS 113
8.2.8 GUIDEWIRES 114
8.2.9 OTHERS 115
8.3 ORTHOPEDIC 116
8.3.1 JOINT REPLACEMENT 118
8.3.1.1 Knee Replacement 119
8.3.1.2 Hip Replacement 119
8.3.1.3 Shoulder Replacement 120
8.3.1.4 Others 121
8.3.2 VISCOSUPPLEMENTATION 122
8.3.3 BIORESORBABLE TISSUE FIXATION 124
8.3.3.1 Suture Anchors 125
8.3.3.2 Interference Screws 125
8.3.3.3 Meniscal Repair Tacks 126
8.3.3.4 Meshes 127
8.3.4 SPINE 127
8.3.4.1 Spinal Fusion 128
8.3.4.2 Minimally Invasive Fusion Surgeries 129
8.3.4.3 Motion Preservation & Dynamic Stabilization 130
8.3.4.3.1 Pedicle-based Rod Systems 131
8.3.4.3.2 Interspinous Spacers 131
8.3.4.3.3 Disc Arthroplasty/Replacement 132
8.3.5 FRACTURE FIXATION 133
8.3.5.1 Bone Plates 134
8.3.5.2 Screws 134
8.3.5.3 Pins 135
8.3.5.4 Rods 135
8.3.5.5 Wires 136
8.3.6 ORTHOBIOLOGICS 136
8.3.6.1 Synthetics Bone Grafts 136
8.4 OPHTHALMOLOGY 137
8.4.1 CONTACT LENSES 139
8.4.2 INTRAOCULAR LENSES 140
8.4.3 FUNCTIONAL REPLACEMENT OF OCULAR TISSUES 141
8.4.4 SYNTHETIC CORNEAS 142
8.4.5 OTHERS 143
8.5 DENTAL 144
8.5.1 DENTAL IMPLANTS 145
8.5.2 DENTAL BONE GRAFTS & SUBSTITUTES 146
8.5.3 DENTAL MEMBRANES 147
8.5.4 TISSUE REGENERATION 148
8.6 PLASTIC SURGERY 148
8.6.1 SOFT TISSUE FILLERS 150
8.6.2 CRANIOFACIAL SURGERY 151
8.7 WOUND HEALING 152
8.7.1 WOUND CLOSURE DEVICES 153
8.7.1.1 Sutures 154
8.7.1.2 Staples 155
8.7.2 SURGICAL HEMOSTATS 156
8.7.3 INTERNAL TISSUE SEALANTS 156
8.7.4 ADHESION BARRIERS 157
8.7.5 HERNIA MESHES 158
8.8 TISSUE ENGINEERING 158
8.8.1 SCAFFOLDS FOR REGENERATIVE MEDICINE 160
8.8.2 NANOMATERIALS FOR BIOSENSING 161
8.8.3 TAILORING OF INORGANIC NANOPARTICLES 162
8.9 NEUROLOGICAL/CENTRAL NERVOUS SYSTEM 162
8.9.1 SHUNTING SYSTEMS 164
8.9.2 CORTICAL NEURAL PROSTHETICS (CNP) 165
8.9.3 HYDROGEL SCAFFOLDS FOR CNS REPAIR 166
8.9.4 NEURAL STEM CELL ENCAPSULATION 167
8.10 OTHER APPLICATIONS 168
8.10.1 DRUG DELIVERY SYSTEMS 170
8.10.2 GASTROINTESTINAL APPLICATIONS 171
8.10.3 BARIATRIC SURGERY 171
8.10.4 URINARY APPLICATIONS 173

9 GLOBAL BIOMATERIALS MARKET, BY REGION 174
9.1 INTRODUCTION 175
9.2 NORTH AMERICA 177
9.2.1 U.S. 179
9.2.1.1 Biomaterials-based Research in the U.S. 179
9.2.1.2 Growing Demand for Plastic Surgeries in the U.S. 180
9.2.1.3 Conferences and Symposiums on Biomaterials in the U.S. 181
9.2.1.4 Increase in Cancer Incidence 181
9.2.1.5 Growing Prevalence of Cardiovascular Diseases 181
9.2.2 CANADA 183
9.2.2.1 Increasing R&D Activities for Biomaterials in Canada 183
9.2.2.2 Growth in Geriatric Population in Canada 183
9.3 EUROPE 185
9.3.1 GERMANY 187
9.3.1.1 Rising Cases of Hip and Knee Replacements 187
9.3.1.2 Growing Medical Devices Industry in Germany 188
9.3.2 U.K. 189
9.3.2.1 Availability of Funds and Grants 189
9.3.2.2 Rise in CVD Prevalence in the U.K. 190
9.3.2.3 Conferences & Annual Meetings 190
9.3.2.4 Rising Volume of Cosmetic Surgeries in the U.K. 190
9.3.3 FRANCE 192
9.3.3.1 Favorable Government Support, Growth in Aging Population 192
9.3.4 SPAIN 193
9.3.4.1 Increasing Research Activities on Biomaterials 193
9.3.5 REST OF EUROPE (ROE) 194
9.3.5.1 Improving Healthcare Structure in Russia 194
9.3.5.2 RoE: Rising Geriatric Population 195
9.3.5.3 Turkey: Growth in the Healthcare Sector, Rising Medical Tourism 195
9.4 ASIA-PACIFIC 196
9.4.1 INTERNATIONAL ALLIANCES 196
9.4.2 JAPAN 199
9.4.2.1 Japan’s Growing Healthcare Industry 199
9.4.3 CHINA 200
9.4.3.1 Lucrative medical devices industry in China 200
9.4.3.2 China’s Favorable Tax Policy 200
9.4.3.3 Growing Aging Population 201
9.4.4 INDIA 202
9.4.4.1 India: A Hotspot for Cosmetic and Plastic Surgery 202
9.4.4.2 High Incidence of Cardiovascular Diseases 202
9.4.4.3 Increasing Geriatric Population 202
9.4.5 REST OF ASIA-PACIFIC (ROAPAC) 203
9.4.5.1 Rising Volume of Hip and Knee Replacement Procedures in Australia 203
9.4.5.2 Indonesia: Regulations Hindering Market Growth 204
9.4.5.3 Increasing Research in Australia, Singapore, and Hong Kong 204
9.5 REST OF THE WORLD (ROW) 205
9.5.1.1 Middle East: Increasing Geriatric Population, Rise in Age-related Disorders 205
9.5.1.2 High Prevalence of Obesity in Latin America 206
9.5.1.3 Opportunities in the Brazilian Market 206
9.5.1.4 Increasing Aging Population, Growing Cardiovascular Disease Prevalence in Brazil 206
9.5.1.5 Market Scenario in Latin America and South Africa 207

10 COMPETITIVE LANDSCAPE 209
10.1 OVERVIEW 209
10.2 COMPARATIVE ASSESSMENT OF KEY PLAYERS IN THE BIOMATERIALS MARKET (2013–2016) 209
10.3 COMPETITIVE SCENARIO 210
10.4 AGREEMENTS, COLLABORATIONS, PARTNERSHIPS, AND JOINT VENTURES 211
10.4.1 PRODUCT LAUNCHES 212
10.4.2 MERGERS AND ACQUISITIONS 214
10.4.3 EXPANSIONS 215
10.4.4 OTHER STRATEGIES 216

11 COMPANY PROFILES 218 (Overview, Financial*, Products & Services, Strategy, and Developments)
11.1 INTRODUCTION 218
11.2 ROYAL DSM 219
11.3 BASF SE 227
11.4 CORBION N.V. 230
11.5 COVESTRO (SUBSIDIARY OF BAYER AG) 233
11.6 INVIBIO LTD. (SUBSIDIARY OF VICTREX PLC) 236
11.7 CARPENTER TECHNOLOGY CORPORATION 238
11.8 EVONIK INDUSTRIES AG 240
11.9 BERKELEY ADVANCED BIOMATERAILS, INC. 243
11.10 CAM BIOCERAMICS BV 244
11.11 CELANESE CORPORATION 245

*Details might not be captured in case of unlisted companies

12 APPENDIX 247
12.1 DISCUSSION GUIDE 247
12.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 260
12.4 AVAILABLE CUSTOMIZATION 260
12.5 RELATED REPORT 261
12.6 AUTHOR DETAILS 262

LIST OF TABLES

TABLE 1 GLOBAL BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD BILLION) 76
TABLE 2 GLOBAL METALLIC BIOMATERIALS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION) 77
TABLE 3 GLOBAL METALLIC BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION) 78
TABLE 4 GLOBAL STAINLESS STEEL BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 79
TABLE 5 GLOBAL TITANIUM & TITANIUM ALLOY BIOMATERIALS MARKET SIZE, BY REGION,  2014-2021 (USD MILLION) 80
TABLE 6 GLOBAL COBALT-CHROME ALLOY BIOMATERIALS MARKET SIZE, BY REGION,  2014-2021 (USD MILLION) 80
TABLE 7 GLOBAL GOLD BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 81
TABLE 8 GLOBAL SILVER BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 81
TABLE 9 GLOBAL MAGNESIUM BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 82
TABLE 10 GLOBAL CERAMIC BIOMATERIALS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION) 83
TABLE 11 GLOBAL CERAMIC BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION) 84
TABLE 12 GLOBAL CALCIUM PHOSPHATE BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 84
TABLE 13 GLOBAL ZIRCONIA BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 85
TABLE 14 GLOBAL ALUMINUM OXIDE BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 86
TABLE 15 GLOBAL CALCIUM SULFATE BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 86
TABLE 16 GLOBAL CARBON BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 87
TABLE 17 GLOBAL GLASS BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 87
TABLE 18 GLOBAL POLYMERIC BIOMATERIALS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION) 88
TABLE 19 GLOBAL POLYMERIC BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION) 89
TABLE 20 GLOBAL POLYMETHYLMETHACRYLATE BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 90
TABLE 21 GLOBAL POLYETHYLENE BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 91
TABLE 22 GLOBAL POLYESTER BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 91
TABLE 23 GLOBAL POLYVINYLCHLORIDE BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 92
TABLE 24 GLOBAL SILICONE RUBBER BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 92
TABLE 25 GLOBAL NYLON BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 93
TABLE 26 GLOBAL POLYETHERETHERKETONE BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 94
TABLE 27 GLOBAL POLYLACTIC ACID, POLY GLYCOLIC ACID, AND POLY(LACTIDE-CO-GLYCOLIDE) BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 95
TABLE 28 GLOBAL OTHER POLYMERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 95
TABLE 29 APPLICATIONS OF NATURAL BIOMATERIALS 96
TABLE 30 GLOBAL NATURAL BIOMATERIALS MARKET SIZE, BY TYPE, 2014-2021 (USD BILLION) 97
TABLE 31 GLOBAL NATURAL BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION) 98
TABLE 32 GLOBAL HYALURONIC ACID BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 99
TABLE 33 GLOBAL COLLAGEN BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 99
TABLE 34 GLOBAL GELATIN BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 100
TABLE 35 GLOBAL FIBRIN BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 100
TABLE 36 GLOBAL CELLULOSE BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 101
TABLE 37 GLOBAL CHITIN BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 101
TABLE 38 GLOBAL ALGINATE BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 102
TABLE 39 GLOBAL SILK BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 103
TABLE 40 BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014–2021 (USD BILLION) 105
TABLE 41 BIOMATERIALS MARKET SIZE FOR CARDIOVASCULAR APPLICATIONS, BY PRODUCT, 2014–2021 (USD BILLION) 107
TABLE 42 BIOMATERIALS MARKET SIZE FOR CARDIOVASCULAR APPLICATIONS, BY REGION, 2014–2021 (USD BILLION) 108
TABLE 43 BIOMATERIALS MARKET SIZE FOR CATHETERS, BY REGION, 2014–2021 (USD BILLION) 109
TABLE 44 BIOMATERIALS MARKET SIZE FOR STENTS, BY REGION, 2014–2021 (USD BILLION) 110
TABLE 45 BIOMATERIALS MARKET SIZE FOR IMPLANTABLE CARDIOVERTER DEFIBRILLATORS, BY REGION, 2014–2021 (USD BILLION) 110
TABLE 46 BIOMATERIALS MARKET SIZE FOR PACEMAKERS, BY REGION, 2014–2021 (USD BILLION) 111
TABLE 47 BIOMATERIALS MARKET SIZE FOR SENSORS, BY REGION, 2014–2021 (USD BILLION) 112
TABLE 48 BIOMATERIALS USED FOR DIFFERENT VALVE COMPONENTS 113
TABLE 49 BIOMATERIALS MARKET SIZE FOR HEART VALVES, BY REGION, 2014–2021 (USD BILLION) 113
TABLE 50 BIOMATERIALS MARKET SIZE FOR VASCULAR GRAFTS, BY REGION, 2014–2021 (USD BILLION) 114
TABLE 51 BIOMATERIALS MARKET SIZE FOR GUIDEWIRES, BY REGION, 2014–2021 (USD BILLION) 114
TABLE 52 BIOMATERIALS MARKET SIZE FOR OTHER CARDIOVASCULAR IMPLANTS/DEVICES, BY REGION, 2014–2021 (USD BILLION) 115
TABLE 53 BIOMATERIALS MARKET SIZE FOR ORTHOPEDIC APPLICATIONS, BY TYPE, 2014–2021 (USD BILLION) 117
TABLE 54 BIOMATERIALS MARKET SIZE FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2014–2021 (USD BILLION) 117
TABLE 55 JOINT REPLACEMENT BIOMATERIALS MARKET SIZE, BY TYPE, 2014–2021 (USD BILLION) 118
TABLE 56 JOINT REPLACEMENT BIOMATERIALS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 118
TABLE 57 KNEE REPLACEMENT BIOMATERIALS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 119
TABLE 58 HIP REPLACEMENT BIOMATERIALS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 120
TABLE 59 SHOULDER REPLACEMENT BIOMATERIALS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 121
TABLE 60 OTHER JOINT REPLACEMENT BIOMATERIALS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 122
TABLE 61 VISCOSUPPLEMENTATION BIOMATERIALS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 123
TABLE 62 BIORESORBABLE BIOMATERIALS MARKET SIZE, BY PRODUCT, 2014–2021 (USD BILLION) 124
TABLE 63 BIORESORBABLE BIOMATERIALS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 124
TABLE 64 BIOMATERIALS MARKET SIZE FOR SUTURE ANCHORS, BY REGION, 2014–2021 (USD MILLION) 125
TABLE 65 BIOMATERIALS MARKET SIZE FOR INTERFERENCE SCREWS, BY REGION, 2014–2021 (USD MILLION) 126
TABLE 66 BIOMATERIALS MARKET SIZE FOR MENISCAL REPAIR TACKS, BY REGION, 2014–2021 (USD MILLION) 126
TABLE 67 BIOMATERIALS MARKET SIZE FOR MESHES, BY REGION, 2014–2021 (USD MILLION) 127
TABLE 68 SPINE BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014–2021 (USD BILLION) 128
TABLE 69 SPINE BIOMATERIALS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 128
TABLE 70 SPINAL FUSION BIOMATERIALS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 129
TABLE 71 BIOMATERIALS MARKET SIZE FOR MINIMALLY INVASIVE FUSION SURGERIES, BY REGION, 2014–2021 (USD MILLION) 129
TABLE 72 BIOMATERIALS MARKET SIZE FOR MOTION PRESERVATION & DYNAMIC STABILIZATION, BY PRODUCT, 2014–2021 (USD MILLION) 130
TABLE 73 BIOMATERIALS MARKET SIZE FOR MOTION PRESERVATION & DYNAMIC STABILIZATION, BY REGION, 2014–2021 (USD MILLION) 130
TABLE 74 BIOMATERIALS MARKET SIZE FOR PEDICLE-BASED ROD SYSTEMS, BY REGION,  2014–2021 (USD MILLION) 131
TABLE 75 BIOMATERIALS MARKET SIZE FOR INTERSPINOUS SPACERS, BY REGION, 2014–2021 (USD BILLION) 132
TABLE 76 BIOMATERIALS MARKET SIZE FOR DISC ARTHROPLASTY/REPLACEMENT, BY REGION, 2014–2021 (USD MILLION) 132
TABLE 77 BIOMATERIALS MARKET SIZE FOR FRACTURE FIXATION, BY PRODUCT, 2014–2021 (USD BILLION) 133
TABLE 78 BIOMATERIALS MARKET SIZE FOR BONE PLATES, BY REGION, 2014–2021 (USD MILLION) 134
TABLE 79 BIOMATERIALS MARKET SIZE FOR SCREWS, BY REGION, 2014–2021 (USD MILLION) 134
TABLE 80 BIOMATERIALS MARKET SIZE FOR PINS, BY REGION, 2014–2021 (USD MILLION) 135
TABLE 81 BIOMATERIALS MARKET SIZE FOR RODS, BY REGION, 2014–2021 (USD MILLION) 135
TABLE 82 BIOMATERIALS MARKET SIZE FOR WIRES, BY REGION, 2014–2021 (USD MILLION) 136
TABLE 83 SYNTHETIC BONE GRAFT BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION) 137
TABLE 84 BIOMATERIALS MARKET SIZE FOR OPHTHALMOLOGY APPLICATIONS, BY PRODUCT, 2014–2021 (USD BILLION) 137
TABLE 85 OPHTHALMOLOGY BIOMATERIALS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 138
TABLE 86 BIOMATERIALS MARKET SIZE FOR CONTACT LENSES, BY REGION, 2014–2021 (USD BILLION) 139
TABLE 87 BIOMATERIALS MARKET SIZE FOR INTRAOCULAR LENSES, BY REGION, 2014–2021 (USD BILLION) 140
TABLE 88 BIOMATERIALS MARKET SIZE FOR FUNCTIONAL REPLACEMENT OF OCULAR TISSUES, BY REGION, 2014–2021 (USD MILLION) 141
TABLE 89 BIOMATERIALS MARKET SIZE FOR SYNTHETIC CORNEAS, BY REGION, 2014–2021 (USD MILLION) 142
TABLE 90 BIOMATERIALS MARKET SIZE FOR OTHER OPHTHALMOLOGY APPLICATIONS, BY REGION, 2014–2021 (USD MILLION) 143
TABLE 91 BIOMATERIALS MARKET SIZE FOR DENTAL APPLICATIONS, BY PRODUCT, 2014–2021 (USD BILLION) 144
TABLE 92 DENTAL BIOMATERIALS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 144
TABLE 93 BIOMATERIALS MARKET SIZE FOR DENTAL IMPLANTS, BY REGION, 2014–2021 (USD BILLION) 146
TABLE 94 BIOMATERIALS MARKET SIZE FOR DENTAL BONE GRAFTS & GRAFT SUBSTITUTES, BY REGION, 2014–2021 (USD MILLION) 146
TABLE 95 BIOMATERIALS MARKET SIZE FOR DENTAL MEMBRANES, BY REGION, 2014–2021 (USD MILLION) 147
TABLE 96 BIOMATERIALS MARKET SIZE FOR TISSUE REGENERATION, BY REGION, 2014–2021 (USD MILLION) 148
TABLE 97 BIOMATERIALS MARKET SIZE FOR PLASTIC SURGERY, BY APPLICATION, 2014–2021 (USD BILLION) 149
TABLE 98 BIOMATERIALS MARKET SIZE FOR PLASTIC SURGERY, BY REGION, 2014–2021 (USD BILLION) 149
TABLE 99 BIOMATERIALS MARKET SIZE FOR SOFT TISSUE FILLERS, BY REGION, 2014–2021 (USD BILLION) 150
TABLE 100 BIOMATERIALS MARKET SIZE FOR CRANIOFACIAL SURGERY, BY REGION, 2014–2021 (USD BILLION) 151
TABLE 101 BIOMATERIALS MARKET SIZE FOR WOUND HEALING APPLICATIONS, BY PRODUCT,  2014–2021 (USD BILLION) 152
TABLE 102 BIOMATERIALS MARKET SIZE FOR WOUND HEALING APPLICATIONS, BY REGION, 2014–2021 (USD BILLION) 152
TABLE 103 BIOMATERIALS MARKET SIZE FOR WOUND CLOSURE DEVICES, BY PRODUCT, 2014–2021 (USD MILLION) 153
TABLE 104 BIOMATERIALS MARKET SIZE FOR WOUND CLOSURE DEVICES, BY REGION, 2014–2021 (USD BILLION) 154
TABLE 105 BIOMATERIALS MARKET SIZE FOR SUTURES, BY REGION, 2014–2021 (USD MILLION) 155
TABLE 106 BIOMATERIALS MARKET SIZE FOR STAPLES, BY REGION, 2014–2021 (USD MILLION) 155
TABLE 107 BIOMATERIALS MARKET SIZE FOR SURGICAL HEMOSTATS, BY REGION, 2014–2021 (USD MILLION) 156
TABLE 108 BIOMATERIALS MARKET SIZE FOR INTERNAL TISSUE SEALANTS, BY REGION, 2014–2021 (USD MILLION) 157
TABLE 109 BIOMATERIALS MARKET SIZE FOR ADHESION BARRIERS, BY REGION, 2014–2021(USD MILLION) 157
TABLE 110 BIOMATERIALS MARKET SIZE FOR HERNIA MESHES, BY REGION, 2014–2021(USD MILLION) 158
TABLE 111 TISSUE ENGINEERING BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014–2021 (USD BILLION) 159
TABLE 112 TISSUE ENGINEERING BIOMATERIALS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 159
TABLE 113 TISSUE ENGINEERING BIOMATERIALS MARKET SIZE FOR SCAFFOLDS FOR REGENERATIVE MEDICINE, BY REGION, 2014–2021(USD MILLION) 161
TABLE 114 TISSUE ENGINEERING BIOMATERIALS MARKET SIZE FOR NANOMATERIALS FOR BIOSENSING, BY REGION, 2014–2021 (USD MILLION) 161
TABLE 115 TISSUE ENGINEERING BIOMATERIALS MARKET SIZE FOR TAILORING OF INORGANIC NANOPARTICLES, BY REGION, 2014–2021 (USD MILLION) 162
TABLE 116 BIOMATERIALS MARKET SIZE FOR NEUROLOGICAL/CNS APPLICATIONS, BY PRODUCT, 2014–2021(USD MILLION) 162
TABLE 117 BIOMATERIALS MARKET SIZE FOR NEUROLOGICAL/CNS APPLICATIONS, BY REGION, 2014–2021 (USD MILLION) 163
TABLE 118 BIOMATERIALS MARKET SIZE FOR SHUNTING SYSTEMS, BY REGION, 2014–2021(USD MILLION) 164
TABLE 119 BIOMATERIALS MARKET SIZE FOR CORTICAL NEURAL PROSTHETICS, BY REGION, 2014–2021 (USD MILLION) 165
TABLE 120 BIOMATERIALS MARKET SIZE FOR HYDROGEL SCAFFOLDS FOR CNS REPAIR, BY REGION, 2014–2021 (USD MILLION) 166
TABLE 121 BIOMATERIALS MARKET SIZE FOR NEURAL STEM CELL ENCAPSULATION, BY REGION, 2014–2021(USD MILLION) 167
TABLE 122 OTHER BIOMATERIAL APPLICATIONS MARKET SIZE, BY TYPE, 2014–2021 (USD MILLION) 168
TABLE 123 OTHER BIOMATERIAL APPLICATIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 169
TABLE 124 BIOMATERIALS MARKET SIZE FOR DRUG DELIVERY SYSTEMS, BY REGION, 2014–2021 (USD MILLION) 170
TABLE 125 BIOMATERIALS MARKET SIZE FOR GASTROINTESTINAL APPLICATIONS, BY REGION, 2014–2021(USD MILLION) 171
TABLE 126 BIOMATERIALS MARKET SIZE FOR BARIATRIC SURGERY, BY REGION, 2014–2021 (USD MILLION) 172
TABLE 127 BIOMATERIALS MARKET SIZE FOR URINARY APPLICATIONS, BY REGION, 2014–2021 (USD MILLION) 173
TABLE 128 BIOMATERIALS MARKET SIZE, BY REGION, 2014-2021 (USD BILLION) 175
TABLE 129 NORTH AMERICA: BIOMATERIALS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION) 178
TABLE 130 NORTH AMERICA: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD BILLION) 178
TABLE 131 NORTH AMERICA: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION) 179
TABLE 132 CONFERENCES AND SYMPOSIUMS ON BIOMATERIALS IN THE U.S. 181
TABLE 133 U.S.: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD BILLION) 182
TABLE 134 U.S.: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION) 182
TABLE 135 CANADA: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD BILLION) 183
TABLE 136 CANADA: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 184
TABLE 137 EUROPE: BIOMATERIALS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION) 186
TABLE 138 EUROPE: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD BILLION) 186
TABLE 139 EUROPE: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION) 187
TABLE 140 GERMANY: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD BILLION) 188
TABLE 141 GERMANY: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 189
TABLE 142 CONFERENCES AND SYMPOSIUMS ON BIOMATERIALS IN U.K. 190
TABLE 143 U.K.: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD BILLION) 191
TABLE 144 U.K.: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 191
TABLE 145 FRANCE: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD MILLION) 192
TABLE 146 FRANCE: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 192
TABLE 147 SPAIN: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD MILLION) 193
TABLE 148 SPAIN: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 194
TABLE 149 GERIATRIC POPULATION IN EUROPEAN COUNTRIES (AS A PERCENTAGE OF THE TOTAL) 195
TABLE 150 ROE: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD MILLION) 195
TABLE 151 ROE: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 196
TABLE 152 ASIA-PACIFIC: BIOMATERIALS MARKET SIZE, BY COUNTRY, 2014-2021 (USD BILLION) 197
TABLE 153 ASIA-PACIFIC: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD BILLION) 198
TABLE 154 ASIA-PACIFIC: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD BILLION) 198
TABLE 155 JAPAN: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD BILLION) 199
TABLE 156 JAPAN: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 200
TABLE 157 CHINA: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD MILLION) 201
TABLE 158 CHINA: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 201
TABLE 159 INDIA: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD MILLION) 202
TABLE 160 INDIA: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 203
TABLE 161 ROAPAC: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD MILLION) 204
TABLE 162 ROAPAC: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 205
TABLE 163 PERCENTAGE OF OBESE POPULATION IN LATIN AMERICAN COUNTRIES 206
TABLE 164 ROW: BIOMATERIALS MARKET SIZE, BY TYPE OF MATERIAL, 2014-2021 (USD BILLION) 208
TABLE 165 ROW: BIOMATERIALS MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION) 208
TABLE 166 AGREEMENTS , COLLABORATIONS, PATNERSHIPS, AND JOINT VENTURES BY COMPANIES (2013–2016) 211
TABLE 167 PRODUCT LAUNCHES BY COMPANIES (2013–2016) 213
TABLE 168 MERGER AND ACQUISITIONS BY COMPANIES (2013–2016) 214
TABLE 169 EXPANSIONS BY COMPANIES (2013–2016) 215
TABLE 170 OTHER STRATEGIES BY COMPANIES (2013–2016) 217

LIST OF FIGURES

FIGURE 1 GLOBAL BIOMATERIALS MARKET SEGMENTATION 24
FIGURE 2 RESEARCH METHODOLOGY: BIOMATERIALS MARKET 26
FIGURE 3 BREAK DOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 28
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 32
FIGURE 5 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 32
FIGURE 6 DATA TRIANGULATION METHODOLOGY 34
FIGURE 7 POLYMERIC BIOMATERIALS SEGMENT TO GROW AT THE HIGHEST RATE DURING THE FORECAST PERIOD 36
FIGURE 8 TITANIUM & TITANIUM ALLOYS SEGMENT IN THE METALLIC BIOMATERIALS MARKET TO REGISTER THE HIGHEST CAGR 37
FIGURE 9 CALCIUM PHOSPHATE SEGMENT IN THE CERAMIC BIOMATERIALS MARKET TO GROW AT THE HIGHEST RATE 38
FIGURE 10 POLYMETHYLMETHACRYLATE SEGMENT TO DOMINATE THE POLYMERIC BIOMATERIALS MARKET IN 2016 39
FIGURE 11 HYALURONIC ACID SEGMENT IN THE NATURAL BIOMATERIALS MARKET TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 40
FIGURE 12 CARDIOVASCULAR SEGMENT TO FORM THE LARGEST APPLICATION SEGMENT IN THE BIOMATERIALS MARKET (2016) 41
FIGURE 13 ASIA-PACIFIC TO WITNESS HIGHEST GROWTH RATE DURING  THE FORECAST PERIOD 42
FIGURE 14 TECHNOLOGICAL ADVANCEMENTS AND GROWTH IN NUMBER OF HIP AND KNEE REPLACEMENT PROCEDURES ARE KEY MARKET DRIVERS 44
FIGURE 15 PLASTIC SURGERY APPLICATION SEGMENT TO WITNESS THE HIGHEST GROWTH DURING THE FORECAST PERIOD 45
FIGURE 16 NORTH AMERICA TO DOMINATE THE BIOMATERIALS MARKET, BY TYPE 46
FIGURE 17 ASIA-PACIFIC TO WITNESS THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 47
FIGURE 18 BIOMATERIALS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 49
FIGURE 19 U.S.: REGULATORY APPROVAL PROCESS 58
FIGURE 20 REGULATORY APPROVAL TIMELINE IN THE U.S. 59
FIGURE 21 EUROPE: REGULATORY APPROVAL PROCESS 62
FIGURE 22 REGULATORY APPROVAL TIMELINE IN EUROPE 63
FIGURE 23 JAPAN: REGULATORY APPROVAL PROCESS 65
FIGURE 24 REGULATORY APPROVAL TIMELINE IN JAPAN 66
FIGURE 25 CHINA: REGULATORY APPROVAL PROCESS 68
FIGURE 26 REGULATORY APPROVAL TIMELINE IN CHINA 69
FIGURE 27 INDIA: REGULATORY APPROVAL PROCESS 70
FIGURE 28 REGULATORY APPROVAL TIMELINE IN INDIA 71
FIGURE 29 AUSTRALIA: REGULATORY APPROVAL PROCESS 73
FIGURE 30 REGULATORY APPROVAL TIMELINE IN AUSTRALIA 74
FIGURE 31 POLYMERIC BIOMATERIALS TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 76
FIGURE 32 TITANIUM AND TITANIUM ALLOYS SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 78
FIGURE 33 GLOBAL CERAMIC BIOMATERIALS MARKET, BY TYPE, 2016 VS 2021 83
FIGURE 34 PMMA SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 89
FIGURE 35 HYALURONIC ACID SEGMENT TO GROW AT THE HIGHEST CAGR DURING THE FORECAST PERIOD 98
FIGURE 36 PLASTIC SURGERY SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 106
FIGURE 37 STENTS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 108
FIGURE 38 JOINT REPLACEMENT TO DOMINATE THE ORTHOPEDIC BIOMATERIALS MARKET DURING THE FORECAST PERIOD 116
FIGURE 39 CONTACT LENSES SEGMENT TO DOMINATE THE OPHTHALMOLOGY BIOMATERIALS MARKET DURING THE FORECAST PERIOD 138
FIGURE 40 DENTAL IMPLANTS SEGMENT TO DOMINATE THE DENTAL BIOMATERIALS MARKET DURING THE FORECAST PERIOD 145
FIGURE 41 SOFT TISSUE FILLERS SEGMENT TO DOMINATE THE PLASTIC SURGERY BIOMATERIALS MARKET DURING THE FORECAST PERIOD 150
FIGURE 42 INTERNAL TISSUE SEALANTS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 153
FIGURE 43 SCAFFOLDS FOR REGENERATIVE MEDICINE SEGMENT REGISTERS LARGEST MARKET SHARE IN 2016 160
FIGURE 44 CORTICAL NEURAL PROSTHETICS SEGMENT TO REGISTER THE HIGHEST CAGR DURING THE FORECAST PERIOD 163
FIGURE 45 DRUG DELIVERY SYSTEMS TO DOMINATE THE OTHER BIOMATERIAL APPLICATIONS MARKET DURING THE FORECAST PERIOD 169
FIGURE 46 NORTH AMERICA TO COMMAND THE LARGEST SHARE OF THE GLOBAL BIOMATERIALS MARKET IN 2016 176
FIGURE 47 NORTH AMERICA: BIOMATERIALS MARKET SNAPSHOT 177
FIGURE 48 EUROPE: BIOMATERIALS MARKET SNAPSHOT 185
FIGURE 49 ASIA-PACIFIC: BIOMATERIALS MARKET SNAPSHOT 197
FIGURE 50 ROW: BIOMATERIALS MARKET SNAPSHOT 207
FIGURE 51 KEY GROWTH STRATEGIES, ADOPTED BY MARKET PLAYERS 210
FIGURE 52 AGREEMENTS, COLLABORATIONS, PATNERSHIPS, AND JOINT VENTURES BY COMPANIES (2013-2016) 211
FIGURE 53 PRODUCT LAUNCHES BY COMPANIES (2013-2016) 212
FIGURE 54 MERGERS AND ACQUISITIONS BY COMPANIES (2013-2016) 214
FIGURE 55 EXPANSIONS BY COMPANIES (2013-2016) 215
FIGURE 56 OTHER STRATEGIES BY COMPANIES (2013-2016) 216
FIGURE 57 PRODUCTS OFFERED BY COMPANIES IN THE BIOMATERIALS MARKET 218
FIGURE 58 COMPANY SNAPSHOT: ROYAL DSM 219
FIGURE 59 COMPANY SNAPSHOT: BASF SE 227
FIGURE 60 COMPANY SNAPSHOT: CORBION N.V 230
FIGURE 61 COMPANY SNAPSHOT: BAYER AG 233
FIGURE 62 COMPANY SNAPSHOT: COVESTRO 234
FIGURE 63 COMPANY SNAPSHOT: VICTREX PLC 236
FIGURE 64 COMPANY SNAPSHOT: CARPENTER TECHNOLOGY CORPORATION 238
FIGURE 65 COMPANY SNAPSHOT: EVONIK INDUSTRIES AG 240
FIGURE 66 COMPANY SNAPSHOT: CELANESE CORPORATION 245

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.